Effect of COVID-19 Pandemic-Related Delays in Chemoembolization on the Survival of Patients with Hepatocellular Carcinoma

Figure 2

Cumulative survival of HCC patients who underwent repeated transarterial chemoembolization (TACE) during the prelockdown and lockdown periods.